Megacariocito (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Megacariocito" in Galician language version.

refsWebsite

Global rank Galician rank

15nih.gov

4^th place

6^th place

12doi.org

2^nd place

7^th place

4archive.org

6^th place

8^th place

archive.org

Bunting S, Widmer R, Lipari T, Rangell L, Steinmetz H, Carver-Moore K, Moore MW, Keller GA, de Sauvage FJ. (1997). "Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin". Blood 90 (9): 3423–3429. PMID 9345025.
Choi ES, Nichol JL, Hokom MM; et al. (1995). "Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional". Blood 85 (2): 402–13. PMID 7529062.
Gordon MS, Hoffman R (1992). "Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia". Blood. 80 (2): 302–307. PMID 1627792.
Ballmaier M, Germeshausen M, Schulze H, Cherkaoui K, Lang S, Gaudig A, Krukemeier S, Eilers M, Strauss G, Welte K (2001). "C-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia". Blood. 97 (1): 139–46. PMID 11133753. doi:10.1182/blood.V97.1.139.

doi.org

dx.doi.org

Branehog I, Ridell B, Swolin B, Weinfeld A (1975). "Megakaryocyte quantifications in relation to thrombokinetics in primary thrombocythaemia and allied diseases". Scand. J. Haematol. 15 (5): 321–332. PMID 1060175. doi:10.1111/j.1600-0609.1975.tb01087.x.
Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE, Hackett NR, Crystal RG, Witte L, Hicklin DJ, Bohlen P, Eaton D, Lyden D, de Sauvage F, Rafii S. (2004). "Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis". Nat Med 10 (1): 64–71. PMID 14702636. doi:10.1038/nm973.
Deutsch VR, Torner A (2006). "Megakaryocyte development and platelet production". Brit. J. Haem. 134 (5): 453–466. PMID 16856888. doi:10.1111/j.1365-2141.2006.06215.x.
Pang L, Weiss MJ, Poncz M (2005). "Megakaryocyte biology and related disorders". J. Clin. Invest. 115 (12): 3332–3338. PMC 1297258. PMID 16322777. doi:10.1172/JCI26720.
Jelkmann W (2001). "The role of the liver in the production of thrombopoietin compared with erythropoietin". Eur. J. Gastroenterol. Hepatol. 13 (7): 791–801. PMID 11474308. doi:10.1097/00042737-200107000-00006.
Murone M, Carpenter DA, de Sauvage FJ (1998). "Hematopoietic deficiencies in c-mpl and TPO knockout mice". Stem Cells. 16 (1): 1–6. PMID 9474742. doi:10.1002/stem.160001.
Nurden AT (2005). "Qualitative disorders of platelets and megakaryocytes". J. Thromb. And Haem. 3 (8): 1773–1782. PMID 16102044. doi:10.1111/j.1538-7836.2005.01428.x.
Michiels JJ, Berneman ZN, Schroyens W, Van Vliet HH (2004). "Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera". Platelets 15 (2): 67–84. PMID 15154599. doi:10.1080/09537100310001646969.
Kralovics R, Passamonti F, Buser AS, Teo SS; et al. (2005-04-28). "A gain-of-function mutation of JAK2 in myeloproliferative disorders". N Engl J Med 352 (17): 1779–90. PMID 15858187. doi:10.1056/NEJMoa051113.
Freedman MH, Estrov Z (1990). "Congenital amegakaryocytic thrombocytopenia: an intrinsic hematopoietic stem cell defect". Am. J. Pediatr. Hematol. Oncol. 12 (2): 225–230. PMID 2378417. doi:10.1097/00043426-199022000-00020.
Ihara K, Ishii E, Eguchi M, Takada H, Suminoe A, Good RA, Hara T (1999). "Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia". Proc. Natl. Acad. Sci. 96 (6): 3133–6. PMC 15907. PMID 10077649. doi:10.1073/pnas.96.6.3132.
Ballmaier M, Germeshausen M, Schulze H, Cherkaoui K, Lang S, Gaudig A, Krukemeier S, Eilers M, Strauss G, Welte K (2001). "C-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia". Blood. 97 (1): 139–46. PMID 11133753. doi:10.1182/blood.V97.1.139.

nih.gov

ncbi.nlm.nih.gov

Branehog I, Ridell B, Swolin B, Weinfeld A (1975). "Megakaryocyte quantifications in relation to thrombokinetics in primary thrombocythaemia and allied diseases". Scand. J. Haematol. 15 (5): 321–332. PMID 1060175. doi:10.1111/j.1600-0609.1975.tb01087.x.
Bunting S, Widmer R, Lipari T, Rangell L, Steinmetz H, Carver-Moore K, Moore MW, Keller GA, de Sauvage FJ. (1997). "Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin". Blood 90 (9): 3423–3429. PMID 9345025.
Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE, Hackett NR, Crystal RG, Witte L, Hicklin DJ, Bohlen P, Eaton D, Lyden D, de Sauvage F, Rafii S. (2004). "Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis". Nat Med 10 (1): 64–71. PMID 14702636. doi:10.1038/nm973.
Deutsch VR, Torner A (2006). "Megakaryocyte development and platelet production". Brit. J. Haem. 134 (5): 453–466. PMID 16856888. doi:10.1111/j.1365-2141.2006.06215.x.
Choi ES, Nichol JL, Hokom MM; et al. (1995). "Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional". Blood 85 (2): 402–13. PMID 7529062.
Gordon MS, Hoffman R (1992). "Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia". Blood. 80 (2): 302–307. PMID 1627792.
Pang L, Weiss MJ, Poncz M (2005). "Megakaryocyte biology and related disorders". J. Clin. Invest. 115 (12): 3332–3338. PMC 1297258. PMID 16322777. doi:10.1172/JCI26720.
Jelkmann W (2001). "The role of the liver in the production of thrombopoietin compared with erythropoietin". Eur. J. Gastroenterol. Hepatol. 13 (7): 791–801. PMID 11474308. doi:10.1097/00042737-200107000-00006.
Murone M, Carpenter DA, de Sauvage FJ (1998). "Hematopoietic deficiencies in c-mpl and TPO knockout mice". Stem Cells. 16 (1): 1–6. PMID 9474742. doi:10.1002/stem.160001.
Nurden AT (2005). "Qualitative disorders of platelets and megakaryocytes". J. Thromb. And Haem. 3 (8): 1773–1782. PMID 16102044. doi:10.1111/j.1538-7836.2005.01428.x.
Michiels JJ, Berneman ZN, Schroyens W, Van Vliet HH (2004). "Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera". Platelets 15 (2): 67–84. PMID 15154599. doi:10.1080/09537100310001646969.
Kralovics R, Passamonti F, Buser AS, Teo SS; et al. (2005-04-28). "A gain-of-function mutation of JAK2 in myeloproliferative disorders". N Engl J Med 352 (17): 1779–90. PMID 15858187. doi:10.1056/NEJMoa051113.
Freedman MH, Estrov Z (1990). "Congenital amegakaryocytic thrombocytopenia: an intrinsic hematopoietic stem cell defect". Am. J. Pediatr. Hematol. Oncol. 12 (2): 225–230. PMID 2378417. doi:10.1097/00043426-199022000-00020.
Ihara K, Ishii E, Eguchi M, Takada H, Suminoe A, Good RA, Hara T (1999). "Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia". Proc. Natl. Acad. Sci. 96 (6): 3133–6. PMC 15907. PMID 10077649. doi:10.1073/pnas.96.6.3132.
Ballmaier M, Germeshausen M, Schulze H, Cherkaoui K, Lang S, Gaudig A, Krukemeier S, Eilers M, Strauss G, Welte K (2001). "C-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia". Blood. 97 (1): 139–46. PMID 11133753. doi:10.1182/blood.V97.1.139.